the GVHR preventing recurrence of leukemia, via a graftversus-leukemia (GVL) effect.
Summary:
the GVHR preventing recurrence of leukemia, via a graftversus-leukemia (GVL) effect.
In the present study, using experimental BMT in a mouse In the present study using an experimental BMT system we analyzed the effects of disparity at non-MHC Ag system we investigated the influence of mismatch at non-MHC loci on acute GVHR. We focused particularly on including minor lymphocyte stimulatory-1 a (Mls-1 a ) Ag on the acute GVH reaction (GVHR) induced by MHC minor lymphocyte stimulatory (Mls)-1 a Ags expressed on host tissue. The Mls-1 a Ag is an endogenous superantigen class I Ag. Mismatch at MHC (class I) Ag alone did not induce clinically detectable acute GVHR in this model.
and stimulates several repertoires of T cells in the absence of priming. 8, 9 It seemed that mismatch at the Mls-1 locus However, BMT mice prepared with a combination of both class I and non-MHC Ag mismatches showed signs between donors and recipients resulted in significant modification of acute GVHR. [10] [11] [12] [13] [14] [15] [16] We report different immunoof clinical GVHR and various cytokines were produced by the spleen cells at an early stage (4 days) after BMT.
logical characteristics seen among donor T cells from various BMT chimeras where MHC and/or minor Ag are Although no clinical GVHR was detected in BMT chimeras prepared with a non-MHC mismatched but MHC matched or mismatched. The Mls-1 disparity significantly modified T cell responses and augmented or altered the matched combination, large amounts of various cytokines were secreted by spleen cells. Cytokine production GVHR generated against MHC via elevated cytokine production. ) mice were obtained from the Shizuoka Laboratory Animal Cooperation, Hamamatsu, Shizuoka Prefecture, Japan. Eight to 9-week-old BMT is a promising therapy for many otherwise lethal disfemale mice were used throughout the study. eases including leukemias.
1 GVHR has been the major problem, resulting in profound tissue damage and often BMT death of the host. The donor for BMT is sought from MHCmatched siblings to minimise GVHR.
2,3 However, there is Recipient mice were lethally irradiated (11 Gy) 24 h before a serious shortage of the MHC matched siblings, and allo-BMT as described elsewhere. [10] [11] [12] To deplete mature T cells geneic BMT numbers are increasing. MHC matching is completely, BM cells (BMC) from donors were treated with important for donor stem cells to successfully reconstitute anti-Thy1.2 moAb (F7D5; Serotec, Olac, Bicester, UK) and the host immune system and for the host to avoid severe selected rabbit C′. Recipients were then inoculated with GVHR.
2-4 In most allogeneic BMTs, MHC matching BMC (1 × 10 7 /mouse) (control chimera mice). GVHR between donors and recipients has been thought to be chimera mice were prepared by inoculation of T cellmandatory. However, the influence of the GVHR which depleted BMC (1 × 10 7 /mouse) plus splenic T cells results from disparity at non-MHC loci between donors and (1 × 10 5 , 1 × 10 6 or 1 × 10 7 /mouse) from the same donor recipients has not been thoroughly clarified. In addition, mice that had been purified with nylon wool columns as beneficial effects of the GVHR have been reported, 5-7 with described elsewhere. 11, 13 For convenience, chimeras prepared by injecting B10.AQR BMC plus splenic T cells into irradiated AKR mice will be referred to as GVHR (B10.AQR → AKR) and BMC alone as control (B10.AQR Correspondence: Dr K Onoé, Institute of Immunological Science,
MLR
irradiated mice. Percent of BW = 100 × average of BW of each day/average of BW of day 0. The MLR was set up in 200 l of RPMI 1640 supplemented with 10% FCS, penicillin (100 U/ml), streptomycin (100 g/ml), and 5 × 10 −5 M 2-ME (culture medium).
Flow cytometry Responder cells (0.5-4 × 10 5 ) and 8 × 10 5 stimulator spleen Chimera mice were sacrificed on the fourth and seventh cells which had been treated with 50 g/ml mitomycin C day after BMT. Spleen and thymus cells were stained as (Kyowa Hakko Kogyo, Tokyo, Japan) were cocultured on described elsewhere. [10] [11] [12] Briefly, in the case of V␤6 staina 96-well flat-bottom culture plate (Falcon; Becton Dickining, cells were first reacted with anti-V␤6 moAb (44-22-son, NJ, USA) as described previously. 9 After 72 h of incu-1). Thereafter, these cells were stained with FITC-anti-rat bation, cell cultures were pulsed with 18 ) and stimulator cells (1 × 10 7 ) were cultured in Diego, CA, USA). Dead cells were electronically gated out 2 ml of culture medium on a 24-well flat-bottom culture from analysis by propidium iodide (Sigma Chemical, St plate (Falcon; Becton Dickinson) for 72 or 96 h and superLouis, MO, USA) staining, forward light scatter (FSC) and natants were collected. To determine cytokine production side light scatter (SSC). All fluorescence analysis was conat between 3 and 4 days of MLR, supernatants were ducted on a FACScan flow cytometer using CELLQuest removed after 72 h of incubation and 2 ml of fresh culture software program. 10, 11 medium with or without stimulator cells were added. These cells were cultured for another 24 h. Thereafter, the supernatants were collected and analyzed as described below. Results
CTLL-2 (IL-2) or CT.4S (IL-4) assay Influences of host Ag on acute GVHR Supernatants were collected from the MLR cultures
To determine the number of inoculated T cells which described above. CTLL-2 or CT.4S cells (5 × 10 3 in 100 l induces non-lethal GVHR in the recipients, splenic T cells culture medium) were incubated in a 96-well culture plate
(1 × 10 5 -1 × 10 7 /mouse) from B10.AQR mice were with the supernatant in the presence or absence of 11B11 injected with T cell-depleted BMC (1 × 10 7 /mouse) into (anti-IL-4 moAb) for 24 h. Cultures were pulsed with lethally (11 Gy) irradiated B10.BR or AKR mice. When 18.5 kBq 3 H-TdR 24 h before harvest. 17 Data shown are the 1 × 10 6 or 1 × 10 7 splenic T cells were transferred with mean of triple cultures.
BMC, obvious GVHR symptoms were seen in GVHR (B10.AQR → B10.BR) as well as in GVHR (B10.AQR → ELISA AKR) mice. Some recipient mice died of severe GVHR. This finding was essentially compatible with our previous Amounts of TNF-␣ and IL-1␣ in the supernatants were report. 10 On the other hand, AKR recipient mice inoculated quantitatively analyzed with the ELISA kits (Genzyme, with 1 × 10 5 splenic T cells plus BMC (GVHR (B10.AQR Cambridge, MA, USA, or Endogen, Cambridge, MA, → AKR)) showed possible GVHR symptoms. No GVHR USA). 18 Amounts of GM-CSF, IL-3 and IFN-␥ were quansigns were detected in B10.BR recipient mice (GVHR titated by ELISA kits purchased from Endogen. Data shown (B10.AQR → B10.BR)) which had received the same numin the present study are the mean of triple cultures.
ber of splenic T cells and BMC from B10.AQR. In subsequent studies, we used GVHR chimera mice in which Spontaneous release of IL-2 or IL-4 1 × 10 5 /mouse T cells were injected, to analyze influences of different host Ags on acute GVHR. Four, 7 or 11 days after BMT, chimera mice were sacriWe first analyzed clinical differences in GVHR among ficed. Spleens were removed, homogenized and a single GVHR chimeras prepared with combinations of H-2 class I cell suspension made from each. One half of the spleen was mismatch, non-MHC Ag mismatch or the both mismatches. cultured in 1 ml culture medium on a 24-well culture plate B10.BR or AKR recipient mice were lethally irradiated and (Falcon; Becton Dickinson) for 24 h. Supernatants were reconstituted with donor BMC with mature T cells (GVHR) analyzed as described above. Negative controls (day 0 data) or without mature T cells (control) as described prewere examined using irradiated mice which had not viously. [10] [11] [12] [13] Figure 1 shows sequential changes of BW of received transplants. Data shown are the mean of triple three kinds of chimeras after BMT and compares the results cultures.
between control and GVHR groups. When (B10.AQR → B10.BR) and (B10.BR → AKR) chimeras were analyzed, Body weight (BW) only a slight or a little difference was detected between control and GVHR groups as shown in Figure 1a and c, BM chimera mice were weighed on the days indicated after BMT. Day 0 data were analyzed using untransplanted, respectively. Both GVHR (B10.AQR → B10.BR) and GVHR (B10.BR → AKR) chimeras recovered their BW at by spleen cells from each group of chimeras (three to five mice/group). Spleen cells from GVHR (B10.AQR → AKR) 2 weeks after BMT to the level before irradiation. No other clinical signs of GVHR were detected in these chimeras 2 chimeras produced significant amounts of IL-4 4 days after BMT ( Figure 2b ). Thereafter, no cytokine release was weeks after BMT. Thus, it appears that the mismatch at H-2 class I or non-MHC Ag alone induces no clinically detectdetected. In the entire period of observation, no IL-2 secretion was detected in the GVHR (B10.AQR → AKR) able GVHR under conditions (T cell number/irradiation dose, etc) used in the present study. On the other hand, in chimeras. When spleen cells from GVHR (B10.BR → AKR) chimthe case of (B10.AQR → AKR) chimeras where H-2 class I plus non-MHC Ag are mismatched, marked reduction of eras were analyzed, marked IL-4 production and slight IL-2 production were observed 4 days after BMT (Figure 2c ). BW was noted in the GVHR group as compared to that in the control group (Figure 1b) . BW of GVHR (B10.AQR → By contrast, spleen cells from GVHR (B10.AQR → B10.BR) chimeras secreted no cytokines at any intervals AKR) chimeras did not recover even 3 weeks after BMT and the GVHR (B10.AQR → AKR) mice showed clinical studied ( Figure 2a ). Since spleen cells from any kinds of control chimeras secreted neither IL-2 nor IL-4, the promisigns of GVHR (ruffled fur and slight hunched back). These results suggest that clinical acute GVHR is induced only nent IL-4 production seen in both GVHR (B10.AQR → AKR) and GVHR (B10.BR → AKR) chimeras appeared to when both H-2 class I and non-MHC Ag are incompatible between donor and recipient mice, at least with the BMT be attributable to donor T cells responding to host non-MHC Ag (Mls-1 a ). 19 conditions used in the present experiments. We then sequentially quantitated the cell numbers recoWe then analyzed various cytokines other than IL-2 and IL-4 in the spleen cell cultures of GVHR (B10.AQR → vered from spleens of (B10.AQR → AKR) and (B10.BR → AKR) chimeras and compared the results between B10.BR), GVHR (B10.BR → AKR) and GVHR (B10.AQR → AKR) as well as control chimeras 4 days after BMT. GVHR and control groups. A significant increase in spleen cell number is noted in GVHR (B10.AQR → AKR) chimSpleen cells from GVHR (B10.BR → AKR) produced considerable amounts of GM-CSF, IL-3, IL-1␣ and IFN-␥ eras as compared with that in control (B10.AQR → AKR) chimeras at day 7 and 11 after BMT (average cell number:
( Figure 3 ) but not TNF-␣ (data not shown). Spleen cells from GVHR (B10.AQR → AKR) chimeras produced slight 1.5 × 10 7 vs 0.4 × 10 7 and 3.7 × 10 7 vs 1.6 × 10 7 , at days 7 and 11, respectively). In contrast, no significant difference amounts of GM-CSF, IL-3, IL-1␣ and IFN-␥. Again, no TNF-␣ was detected (data not shown). In spleen cell culwas observed between GVHR and control groups when (B10.BR → AKR) chimeras were analyzed and compared tures of GVHR (B10.AQR → B10.BR) and any control chimeras, no detectable level of cytokines was secreted. (average cell number: 1.3 × 10 7 vs 1.1 × 10 7 and 2.1 × 10 7 vs 1.7 × 10 7 , at days 7 and 11, respectively). Although we Thus, in the absence of significant cytokine production no evidence of GVHR was detected in GVHR (B10.AQR → did not determine the origin of proliferating spleen cells, it appeared that the marked clinical signs of GVHR seen in B10.BR) chimeras. However, GVHR (B10.BR → AKR) in which prominent cytokine production was observed showed GVHR (B10.AQR → AKR) chimeras were associated with the considerable proliferation of spleen cells.
no clinical evidence of GVHR. It seemed that allogeneic responses against non-MHC Ag (Mls-1 a ) alone were insufficient to induce clinical levels of acute GVHR. We conSequential changes of IL-2 and IL-4 productions by sidered that in GVHR (B10.AQR → AKR) chimeras donor spleen cells from GVHR chimeras T cells responding to Mls-1 a might augment the T cell responses against MHC class I Ag by secreting various We then sequentially analyzed cytokine (IL-2 and IL-4) production in spleen cells obtained from three kinds of cytokines. chimeras 4, 7 and 11 days after BMT. A single cell suspension prepared from a half spleen from each chimera was MLR and cytokine production cultured for 24 h without any stimulants and amounts of IL-2 and IL-4 in the supernatants were quantitated. Figure 2 To elucidate the different roles of the host Ag in allogeneic immune responses, we then analyzed immunological shows means of the spontaneous release of IL-2 and IL-4 production, these results are consistent with those of BMT chimeras and indicate that T cells stimulated with class I mice generated considerably higher proliferative responses upon stimulation with AKR stimulators than did those plus minor Ag produce larger amounts of cytokines than those stimulated with class I Ag alone. stimulated with B10.BR stimulators (Figure 4a) . Thus, the difference in non-MHC Ag appeared to augment additively When MLRs between responders from B10.BR mice and stimulators from AKR mice were carried out, the responder the proliferative responses. We then quantitated productions of IL-1␣ (Figure 4b a Ag was mainly involved in the cytokine production. 9, 19 When cytokine production between 3 present in the spleen of GVHR (B10.BR → AKR) chimeras 4 days after BMT. More than half of the donor (Thy1.2 + ) and 4 days of MLR were quantitated, quite large amounts of IL-4 were detected irrespective of the addition of fresh T cells are V␤6 + (Figure 6b ). No V␤6 + T cells were detected in control (B10.BR → AKR) chimeras (data not stimulators at day 3 of the MLR (Figure 5e ). On the other hand, IL-2 production was not detected between days 3 and shown). Thus, it seems that the increasing V␤6 + T cells in the spleen of GVHR (B10.BR → AKR) chimeras are cells 4 of the MLR (Figure 5d ). Thus, it appeared that IL-4 was produced at later stages as compared with IL-2.
producing large amounts of IL-4 and other cytokines (Figures 2 and 3) . On the other hand, only a small proportion of V␤6 + T cells was observed in GVHR Cell population in spleens of GVHR chimeras (B10.AQR → AKR) chimeras (Figure 6a ). Since no V␤6 + T cells (0.0%) were detected in control We then analyzed cell populations of the spleens from (B10.AQR → AKR) and (B10.BR → AKR) 4 and 7 days (B10.AQR → AKR) chimeras, the small number of V␤6 + T cells appeared to be related to the GVHR seen in these after BMT and compared the proportion of donor T cells between GVHR and control groups. Figure 6 shows a repmice. These findings are compatible with the previous results that slight amounts of IL-4, GM-CSF, IL-3 and ILresentative FACS profile of the splenic population from the GVHR chimeras (Figure 6e and f) . This finding suggests that IL-4-producing cells do not reside in the NK1.1 + population in our chimera system.
Discussion
GVHR has been considered one of the most critical problems after BMT.
2,3,12-16,22,23 Although both CD4 + and CD8 + T cells participate in the GVHR, these two T cell subsets cause different patterns of GVHR which depend upon the target MHC Ag on host cells. 2,24,25 Further, it has been repeatedly reported that disparity at non-MHC loci also induces variable degrees of GVHR. 26, 27 However, thus far, the precise role(s) of the non-MHC Ag in induction of acute GVHR after BMT has not been thoroughly elucidated.
In the present study, we analyzed GVHR generated by disparity at either MHC class I, non-MHC Ag or both at very early periods after BMT. Clinical signs of the acute GVHR were detected only in GVHR (B10.AQR → AKR) chimeras where both class I and non-MHC Ag were mismatched. By contrast, GVHR (B10.AQR → B10.BR) chimeras mismatched at the MHC class I, or GVHR (B10.BR → AKR) chimeras mismatched at the non-MHC loci exhibited no clinical signs of GVHR. These findings may permit us to conclude that acute GVHR is generated in the presence of both MHC class I reactive T cells and those reactive with non-MHC Ag. The synergistic effect of CD4 + T cells and CD8 + T cells on the GVHR has been reported earlier. 13, 24, 25 However, clear differences in clinical signs of acute GVHR seen between GVHR It should be noted that prominent production of various cytokines was observed in spleen cells from GVHR These results are compatible with our previous studies.
11 -13 The V␤6
+ T cells appeared to continue proliferating (B10.BR → AKR) 4 days after BMT, which paralleled the increase of V␤6 + T cells in the spleen. In spite of the conbetween 4 and 7 days after BMT but no longer produced IL-4 at day 7 (Figure 2) . tinued increase in V␤6 + T cells, production of IL-4 was rapidly decreased thereafter. Perhaps these V␤6 + T cells It has been reported that NK1.1 + TCR␣/␤ + cells produce large amounts of IL-4 at an early period after stimuwere undergoing activation-induced cell death (AICD). 19, 30 In our previous study, 12 we observed that the V␤6 + T cells lation. 20, 21 To elucidate the contribution of NK1.1 + TCR␣/␤ + cells on the prominent IL-4 production present in the spleen and thymus of GVHR (B10.AQR → AKR) chimeras 5 weeks after BMT were not by spleen cells (Figure 2) , we examined the proportion of NK1.1 Slight production of IL-4 and other cytokines was also detected in spleen cells from GVHR (B10.AQR → AKR) chimeras 4 days after BMT. The minimal cytokine production, as compared to that seen in GVHR (B10.BR → AKR) chimeras, may be explained by a small population size of V␤6 + T cells in the spleen of GVHR (B10.AQR → AKR) mice 4 days after BMT (Figure 6 ), because significant cytokine production was seen in B10.AQR vs AKR MLR. In the presence of disparity at the MHC class I loci, the small amount of cytokines produced by Mls-1 a reactive T cells might be sufficient to induce a detectable level of acute GVHR (Figure 1) . However, how the various cytokines augment the GVHR remains unclear. We were unable to detect TNF-␣ production in spleen cell cultures of GVHR chimeras which has been reported to mediate loss of BW. 31 In addition it has been reported that the Th2 type cytokines (ie IL-4) prevented the GVHR, 32 although IL-4 might be involved in B cell hyperactivity and impairment of Th1-like activities in chronic GVHR. 33 At day 7, quite high proportions of V␤6 + donor T cells were observed in GVHR (B10.AQR → AKR) chimeras. Thus, in these chimeras the peak of cytokine production may be a few days late as compared to that in GVHR 
